文献速递临床试验与 GCP

PROPENSIX:使用压缩动态莱卡袖套的压力衣疗法改善单侧脑瘫双手机能的多中心随机对照试验方案

PROPENSIX: pressure garment therapy using compressive dynamic Lycra® sleeve to improve bi-manual performance in unilateral cerebral palsy: a multicenter randomized controlled trial protocol.
PubMed 文献 · Trials · 2022-02-05

PROPENSIX是一项多中心、前瞻性、安慰剂对照、双盲随机试验,计划纳入100例5至10岁单侧脑瘫儿童,按1:1随机分配在日常活动中穿戴莱卡袖套或安慰剂袖套6个月。主要终点为入组至6个月时辅助手评估(AHA)测量的双手机能变化,次要终点涵盖ICF其他维度、上肢运动能力、健康相关生活质量及身体结构与功能。

要点

  • 纳入5至10岁单侧脑瘫儿童100例,1:1随机穿戴莱卡袖套或安慰剂袖套6个月。
  • 主要终点为入组至6个月辅助手评估(AHA)测量的双手机能变化。
  • 次要终点包括ICF其他维度、QUEST上肢运动能力、PedsQL 3.0脑瘫模块及神经骨科检查与体感诱发电位。

核心结论

  • PROPENSIX是评估压缩动态莱卡袖套压力衣疗法治疗单侧脑瘫的最大随机对照试验。
  • 6个月穿戴结束时双手机能的改善应能增加该疗法的证据并拓展其临床推荐讨论。
  • 次要结局数据应能为讨论莱卡袖套对单侧脑瘫儿童活动能力、肌张力和感觉障碍的作用提供论据。

研究设计与样本

  • 多中心、前瞻性、安慰剂对照、双盲随机对照试验方案。
  • 计划纳入100例5至10岁单侧脑瘫儿童,按1:1随机分配。
  • 两组均在6个月内进行日常活动(尤其涉及双手的活动)时穿戴莱卡袖套或安慰剂袖套。
  • 试验注册号ClinicalTrials.gov NCT02086214,于2014年3月13日回顾性注册。
  • 研究开始日期2012年12月,招募状态为已完成,主要完成日期2021年4月,预计研究完成日期2022年12月,方案版本10(日期2018年2月)。

主要发现

  • 主要终点为入组至6个月时辅助手评估(AHA)测量的双手机能变化。
  • 次要终点评估入组至6个月时国际功能分类(ICF)其他维度的变化。
  • 次要终点包括质量上肢技能测试(QUEST)评估的上肢运动能力变化。
  • 次要终点包括儿童生活质量量表3.0脑瘫模块(PedsQLTM 3.0 CP Module)评估的健康相关生活质量变化。
  • 次要终点包括神经骨科检查和体感诱发电位(SEP)评估的身体结构与功能域变化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Upper limb impairment affects activity and participation in children with unilateral cerebral palsy (UCP). Pressure garment therapy (PGT) using compressive dynamic Lycra® garments is an innovative intervention proposed for the management of cerebral palsy consequences. The PROPENSIX study aims to evaluate the efficacy of a therapy using a Lycra® sleeve as compared to a placebo sleeve to improve bi-manual performance measured by the Assisting Hand Assessment (AHA) in children with unilateral cerebral palsy. METHODS: The PROPENSIX trial is a multicenter, prospective, placebo-controlled, double-blinded, randomized study. One hundred children with UCP, aged from 5 to 10, are randomly assigned as soon as they are recruited in a 1:1 ratio to perform usual daily activities, especially activities involving bimanual performances, with Lycra® sleeve or placebo sleeve during 6 months. The primary endpoint is the change in bimanual performance from inclusion to 6 months, evaluated by AHA. The secondary endpoints evaluate changes from inclusion to 6 months in other dimensions of the International Classification of Functioning (ICF), upper limb movement capacity assessed by Quality of Upper Extremity Skill Test (QUEST), and health-related quality of life evaluated by Pediatric Quality of Life Inventory 3.0 Cerebral Palsy Module (PedsQLTM 3.0 CP Module) and in body structures and functions domain assessed by neuro-orthopedic examination and somatosensory evoked potentials (SEP). DISCUSSION: The PROPENSIX study is the largest randomized controlled trial (RCT) aiming to evaluate the efficacy of a PGT using compressive dynamic Lycra® sleeve in UCP. Enhancement of children's bimanual performance at the end of the 6 months wear of the Lycra® sleeve should improve evidence regarding this type of treatment and expand discussion about their recommendation in clinical practice. Data from secondary outcomes assessments should bring interesting arguments to discuss the Lycra® sleeve action on mobility, tonus, and sensory impairments in children with unilateral cerebral palsy. TRIAL REGISTRATION: ClinicalTrials.gov NCT02086214 . Retrospectively registered on March 13, 2014 TRIAL STATUS: Study start data: December 2012. Recruitment status: completed. Primary completion date: April 2021. Estimated study completion date: December 2022. Protocol version 10 (date: February 2018).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Gerard A, Toussaint-Thorin M, Mohammad Y, et al. PROPENSIX: pressure garment therapy using compressive dynamic Lycra® sleeve to improve bi-manual performance in unilateral cerebral palsy: a multicenter randomized controlled trial protocol. Trials. 2022. PMID: 35123557. doi:10.1186/s13063-022-06041-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。